What the Allergist Needs to Know about Monoclonal Antibody Therapy

Price: FREE for members, $25 for non-members

This webinar addresses key information that allergists need to know regarding the FDA Emergency Use Authorization of monoclonal antibodies in the treatment of COVID-19. 

This webinar is sponsored by GlaxoSmithKline.

Target Audience

Allergists/Immunologists

Learning Objectives

  • Apply the most current FDA guidelines for the use of monoclonal antibodies.
  • Describe the mechanisms and current data
  • Evaluate their COVID-19 patients using the High-Risk Criteria for appropriate use of monoclonal antibody therapy
  • Describe benefits and risks and special considerations of these therapies and procedures to refer for administration
Additional information
Disclosure: 

N/A

Course summary
Course opens: 
08/31/2021
Course expires: 
08/30/2024
Cost:
$25.00
Rating: 
0

Daniel Ein, MD, FACAAI Emeritus

Lisa Davidson, MD, FIDSA

Gailen D. Marshall, MD, PhD, FACAAI

Price

Cost:
$25.00
Please login or create an account to take this course.